Tag: FDA Orange Book

Authorized Generics: The Brand-Name Drug at a Generic Price

Discover how authorized generics offer the exact same formula as brand-name drugs at lower prices. Learn the differences from traditional generics, insurance coverage, and when to switch for better value.

Read more

Paragraph IV Patent Challenges: How Generic Makers Challenge Brands

Discover how generic drug manufacturers use Paragraph IV certifications to challenge brand-name patents under the Hatch-Waxman Act. Learn about the 180-day exclusivity, FDA approval timelines, and the economic impact on drug prices.

Read more

FDA Orange Book: Where to Find Patent Expiration Dates for Generic Drug Entry

Learn where to find patent expiration dates in the FDA Orange Book to predict when generic drugs become available. Understand how patents, exclusivity, and extensions affect market entry.

Read more

Pharmacist Responsibilities When Dispensing Generics: Legal Obligations in the U.S.

Pharmacists must follow strict legal rules when dispensing generic drugs. Learn how state laws, FDA guidelines, and consent requirements shape their responsibilities-and what happens when they get it wrong.

Read more

FDA Orange Book: How Approved Generic Drugs Are Listed

The FDA Orange Book lists approved generic drugs and tells pharmacists which ones can safely replace brand-name medications. It's the key to lower drug prices in the U.S.

Read more